Navigation Links
Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
Date:8/24/2010

grams/prolindac/">ProLindac™, currently in Phase II clinical testing of patients with ovarian cancer, and MuGard™ for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin™-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our cash burn rate, clinical trial plans and timelines and clinical results for ProLindac, MuGard, Thiarabine and Cobalamin and other product candidates, our ability to achieve clinical and commercial success and our ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.Contact: CompanyContact: Investor RelationsChristine BerniDonald C. Weinberger/Diana Bittner (media)Director of Investor RelationsWolfe Axelrod We
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
2. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
3. DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions
4. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
5. Chinas first open-access journal Nano Research listed in Science Citation Index
6. Sudek of Tech Coast Angels Announces Networks Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs
7. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe
8. Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
9. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
10. Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
11. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 A study presented at the ... efficacy of CSL Behring,s C1 Inhibitor (C1-INH) concentrate ... highly sensitized patients. C1-INH is a human protein ... The study shows that post-transplant treatment ... levels of complement components 3 and 4, suggesting ...
(Date:7/30/2014)... AZ (PRWEB) July 30, 2014 Sales ... the launch of blended sales training programs for companies ... sales training programs used by thousands of salespeople over ... blended sales training program can be customized to address ... , The blended sales training program consists ...
(Date:7/30/2014)... PA (PRWEB) July 30, 2014 Vycom ... family of products, designed to meet Factory Mutual (FM) ... equipment materials such as wet benches, process tools, fume ... worker safety and damage to semiconductor wafers used in ... provides a flame-retardant PVC solution with excellent workability and ...
(Date:7/30/2014)... July 30, 2014   Epic Sciences, Inc. ... novel diagnostics to personalize and advance the treatment and ... Gregory T. Lucier as chairman of Epic,s board ... of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s ... its circulating rare cell analysis platform with special focus ...
Breaking Biology Technology:Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3
... Florida researcher may have found a defense against the Black ... population in the Middle Ages and which government agencies perceive ... Daniell and his team have developed a vaccine that early ... his National Institutes of Health and USDA funded research appear ...
... September 2, 2008 -- A new interactive web lesson ... are developed. The lesson, developed by William E. Dyer, ... the Journal of Natural Resources and Life Sciences ... , Surprisingly, almost all of the herbicides on the ...
... BioInformatics, LLC,( http://www.gene2drug.com ), the leading market ... industry, announces the publication of its latest,report, ... and,Biologists." A joint effort between BioInformatics, LLC ... designed to help suppliers of protein,research tools ...
Cached Biology Technology:UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3Protein Research Marketing Insights 2Protein Research Marketing Insights 3
(Date:7/30/2014)... Laboratory has received a pledge of $1 million from ... the Laboratory,s new Neurobehavioral Biometry Center. , ... will enable the Laboratory to develop a greater breadth ... ultimate goal of accelerating the pace of research to ... as a premier resource for the Laboratory and its ...
(Date:7/30/2014)... HIV infection could be as simple as inserting a ... University of Washington bioengineers have discovered a potentially faster ... from contracting HIV. Their method spins the drug into ... moisture, releasing higher doses of the drug than possible ... , "This could offer women a potentially more effective, ...
(Date:7/30/2014)... , July 30, 2014 NexID ... and liveness detection solutions for the biometric authentication ... industry consortium revolutionizing online authentication with standards for ... Cornett , "The decision to join FIDO Alliance ... authentication pervasive in use. We believe the FIDO ...
Breaking Biology News(10 mins):Rossi Foundation pledges $1M for JAX neurobehavioral research center 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3NexID Biometrics Joins the FIDO Alliance 2
... another reason why you should listen to your mother ... a chemical present at high levels in a precursor ... etc.), helps prevent the severe blistering and skin breakage ... disease epidermolysis bullosa simplex (EBS). The researchers treated ...
... Colorado at Boulder team excavating an ancient Maya village in ... has discovered an ancient field of manioc, the first evidence ... The manioc field was discovered under roughly 10 feet ... been directing the excavation of the ancient village of Ceren ...
... Researchers from Boston University School of Medicine (BUSM) ... HIV disease progression in HIV-infected persons. The study ... Journal of Acquired Immune Deficiency Syndromes., Alcohol use ... on HIV disease progression has been examined in ...
Cached Biology News:Natural chemical found in broccoli helps combat skin blistering disease 2CU-Boulder team discovers first ancient manioc fields in Americas 2CU-Boulder team discovers first ancient manioc fields in Americas 3Study shows link between alcohol consumption and hiv disease progression 2